These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35929960)

  • 21. Cell membrane-based nanomaterials for therapeutics of neurodegenerative diseases.
    Nguyen-Thi PT; Nguyen TT; Phan HL; Ho TT; Vo TV; Vo GV
    Neurochem Int; 2023 Nov; 170():105612. PubMed ID: 37714337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered bacterial extracellular vesicles for central nervous system diseases.
    Ji N; Wang F; Wang M; Zhang W; Liu H; Su J
    J Control Release; 2023 Dec; 364():46-60. PubMed ID: 37866404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicle-associated lipids in central nervous system disorders.
    Vanherle S; Haidar M; Irobi J; Bogie JFJ; Hendriks JJA
    Adv Drug Deliv Rev; 2020; 159():322-331. PubMed ID: 32360577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanostructures and Nanotechnologies for the Detection of Extracellular Vesicle.
    Ye S; You Q; Song S; Wang H; Wang C; Zhu L; Yang Y
    Adv Biol (Weinh); 2023 Feb; 7(2):e2200201. PubMed ID: 36394211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered EVs designed to target diseases of the CNS.
    Nieland L; Mahjoum S; Grandell E; Breyne K; Breakefield XO
    J Control Release; 2023 Apr; 356():493-506. PubMed ID: 36907561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Panorama of Extracellular Vesicle Applications: From Biomarker Detection to Therapeutics.
    Das S; Lyon CJ; Hu T
    ACS Nano; 2024 Apr; 18(14):9784-9797. PubMed ID: 38471757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advances on Extracellular Vesicles in Central Nervous System Diseases.
    Jin T; Gu J; Li Z; Xu Z; Gui Y
    Clin Interv Aging; 2021; 16():257-274. PubMed ID: 33603351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular vesicles in cardiovascular disease.
    Huang C; Neupane YR; Lim XC; Shekhani R; Czarny B; Wacker MG; Pastorin G; Wang JW
    Adv Clin Chem; 2021; 103():47-95. PubMed ID: 34229852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular vesicles: Critical bilateral communicators in periphery-brain crosstalk in central nervous system disorders.
    Wang D; Guan S; Lu P; Li Y; Xu H
    Biomed Pharmacother; 2023 Apr; 160():114354. PubMed ID: 36753954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harnessing the Therapeutic Potential of Extracellular Vesicles for Biomedical Applications Using Multifunctional Magnetic Nanomaterials.
    Yang L; Patel KD; Rathnam C; Thangam R; Hou Y; Kang H; Lee KB
    Small; 2022 Apr; 18(13):e2104783. PubMed ID: 35132796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular vesicles for the treatment of central nervous system diseases.
    Gratpain V; Mwema A; Labrak Y; Muccioli GG; van Pesch V; des Rieux A
    Adv Drug Deliv Rev; 2021 Jul; 174():535-552. PubMed ID: 33991589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
    Sa P; Singh P; Dilnawaz F; Sahoo SK
    Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA Nanomaterial-Empowered Surface Engineering of Extracellular Vesicles.
    Yao X; He D; Wei P; Niu Z; Chen H; Li L; Fu P; Wang Y; Lou S; Qian S; Zheng J; Zuo G; Wang K
    Adv Mater; 2023 Dec; ():e2306852. PubMed ID: 38041689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular Vesicles in Molecular Diagnostics: An Overview with a Focus on CNS Diseases.
    Hirshman BR; Kras RT; Akers JC; Carter BS; Chen CC
    Adv Clin Chem; 2016; 76():37-53. PubMed ID: 27645815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomaterials for Molecular Detection and Analysis of Extracellular Vesicles.
    Taylor ML; Giacalone AG; Amrhein KD; Wilson RE; Wang Y; Huang X
    Nanomaterials (Basel); 2023 Jan; 13(3):. PubMed ID: 36770486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-Based Nanomaterials for Analysis of Extracellular Vesicles.
    Deng J; Liu C; Sun J
    Adv Mater; 2024 May; 36(22):e2303092. PubMed ID: 38016069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bio-inspired nano tools for neuroscience.
    Das S; Carnicer-Lombarte A; Fawcett JW; Bora U
    Prog Neurobiol; 2016 Jul; 142():1-22. PubMed ID: 27107796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.
    Wu M; Wang M; Jia H; Wu P
    Drug Deliv; 2022 Dec; 29(1):2513-2538. PubMed ID: 35915054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced extracellular vesicle production and ethanol-mediated vascularization bioactivity via a 3D-printed scaffold-perfusion bioreactor system.
    Patel DB; Luthers CR; Lerman MJ; Fisher JP; Jay SM
    Acta Biomater; 2019 Sep; 95():236-244. PubMed ID: 30471476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.